Big E
Dec 9
Big E’s Big Mouth Substack

An Assassin's Pistol and a Possible Motive. The killer of Brian Thompson favored silence over speed. By JOHN LEAKE (12/08/24)

petermcculloughmd.subst…

This article covers speculations about why UnitedHealthcare (UHC) CEO Brian Thompson may have been murdered and the weapon used. But the key take-away is its description of how the CARES Act dictated the hospital protocols that killed so many people and left others with lifelong debilitating medical conditions.

Bottom line: The CARES Act of March 25, 2020 enabled monstrous and murderous Medicare and Medicaid fraud at taxpayer expense.

Key Points…

Distilled from: Summary of the article’s quoted section from “The Courage to Face COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex.” By John Leake and Dr. Peter McCullough: a.co/d/hwyS2I2

ED NOTE
We apologize for any mistakes distilling this article into its key points. There was a lot to unpack. Please refer to the full article, the book, or the references in this Note for details.

CARES Act of March 25, 2020 (Assistance to Hospitals):

  • Created and disbursed vast federal funds to hospitals to assist them in dealing with the emergency: $100 billion, “a portion of which will be used to reimburse healthcare providers, at Medicare rates, for COVID-related treatment of the uninsured.”

  • Created a 20% add-on for Medicare patients with COVID-19.

  • Paid a fee for performing a Covid test, for admitting a Covid positive patient, and then the full daily Medicare (with a 20% add-on) hospitalization rate, regardless of the patient’s insurance status.

Death Certificates:

CDC guidance allowed reporting of COVID-19 on a death certificate as “probable” or “presumed” even if a definitive COVID-19 cannot be made, but is suspected or likely.

  • Death of any patient — including frail patients with multiple co-morbidities — with flu-like or pneumonia symptoms, could be attributed to COVID-19, even without a positive test.

  • April 8, 2020: Dr. Anthony Fauci dismissed concerns about COVID-19 death coding as “a conspiracy theory,” ignoring many well-documented cases of fraud due to perverse incentives of a 20% add-on Medicare rate for all patients, regardless of age, insurance status, and citizenship, or the level of hospital care given.

Perverse Hospital Incentives:

Coding and Billing: Hospitals were incentivized to code patients as COVID-19 admissions even if they were suffering from other illnesses or injuries. Per Dr. Scott Jensen:

  • Medicare payment for a COVID-19 admission to hospital: $13,000

  • Putting a COVID-19 patient on a ventilator: $39,000

Drug Therapies:

November 2, 2020: Centers for Medicare and Medicaid Services (CMS) announced an additional 20% add-on payment to hospitals that used FDA-approved COVID-19 drugs including remdesivir (Gilead Sciences, manufacturer) and convalescent plasma (extracted from donated blood) for treatment of COVID-19.

Thus, Medicare paid hospitals a 20% gratuity on the patient’s entire hospital bill (already “enhanced” 20%) for using these drugs.

Timeline:

  • October 9, 2020: NIH treatment guidelines failed to recommend successful strategies for treating pulmonary inflammation with methylprednisolone and micro-thrombosis with anti-coagulants. These strategies were part of the MATH+ protocol.

  • October 2020: FLCCC’s MATH+ protocol added ivermectin as a core medication to prevent and treat COVID-19. Previously, MATH+ recommended methylprednisolone, ascorbic acid, thiamine, and heparin combo (pubmed.ncbi.nlm.nih.gov…)

  • November 2, 2020: CMS 20% add-on payment for remdesivir and convalescent plasma, described above.

  • November 20, 2020: WHO recommended against using remdesivir.

  • Convalescent plasma supplies depended on blood donation, but remdesivir supply was unconstrained. Thus, remdesivir became the “standard” hospital treatment for COVID-19.

  • Remdesivir costs about $10 per dose to manufacture. Medicare covered it at $3,100 per treatment course. Some patients were given multiple rounds of remdesivir. Gilead Sciences booked $1.9 billion in revenue for 2020 Q4, and $5.6 billion in 2021.

Ventilators: During 2020, hospital experience proved mechanical ventilation did not overcome pulmonary inflammation and thrombosis causing SARS, didn’t help patients, often injured the lungs, and further contributed to their deaths.

Concluding Questions:

  1. Could CARES Act enhanced payments explain why hospitals stuck with the NIH’s treatment guidelines despite their low success rate?

  2. Could hospitals have refused to use the successful FLCCC’s MATH+ (with ivermectin) protocol because it could imperil the 20% enhanced Medicare payment for COVID-19 patients, plus the 20% add-on for administering these patients remdesivir, plus the $39,000 payment for mechanical ventilation?

CARES Act:

Remdesivir Side Effects:

FLCCC MATH+ Protocol (updated): covid19criticalcare.com…

Dec 9
at
3:33 PM